The matchup looks lopsided: America's giant drug companies vs. a midsize college over billions of dollars in royalties from a new class of "super aspirin." At the heart of the clash between the University of Rochester and the pharmaceutical behemoths is one question: Should schools get a share of the riches if they make a fundamental discovery and secure a patent but don't set down a clear path to developing a commercial product?
March 26, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Cozen O Connor is seeking an associate with at least three years of experience defending clients in employment litigation matters to join th...
Busy and growing general practice seeks NY admitted associate, with 3+ years experience in divorce/family law. The ideal candidate will be a...
Boutique downtown Manhattan firm seeking an experienced litigation associate with experience in landlord-tenant and real estate litigation. ...
Snyder Sarno D'Aniello Maceri & daCosta would like to announce that...
COLE SCHOTZ P.C. WELCOME HONORABLE GARRY S. ROTHSTADT, J.A.D. (RET.)
GREENBAUM ROWE SMITH & DAVIS LLP would like to announce that...
